SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-067604
Filing Date
2012-02-17
Accepted
2012-02-17 16:53:51
Documents
9
Period of Report
2012-02-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d300638d8k.htm 8-K 24749
2 UNDERWRITING AGREEMENT d300638dex11.htm EX-1.1 283144
3 FORM OF WARRANT d300638dex41.htm EX-4.1 88416
4 OPINION OF COOLEY LLP d300638dex51.htm EX-5.1 9718
5 PRESS RELEASE d300638dex991.htm EX-99.1 11258
6 PRESS RELEASE d300638dex992.htm EX-99.2 12237
7 GRAPHIC g300638g02o73.jpg GRAPHIC 7633
8 GRAPHIC g300638g39b37.jpg GRAPHIC 20618
9 GRAPHIC g300638g39r64.jpg GRAPHIC 19036
  Complete submission text file 0001193125-12-067604.txt   496224
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51820 | Film No.: 12623332
SIC: 2834 Pharmaceutical Preparations